v3.25.4
Consolidated Balance Sheets - USD ($)
Dec. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 3,000 $ 1,999,000
Accounts receivable 5,000
Inventory 63,000
Current portion of notes receivable 198,000 184,000
Prepaid expenses and other current assets 142,000 265,000
Total current assets 411,000 2,448,000
Property, plant and equipment, net 17,000
Notes receivable 17,000
Other intangible assets, net 16,994,000 17,808,000
Total assets 17,405,000 20,290,000
Current liabilities:    
Accounts payable 347,000 314,000
Accrued expenses 194,000 194,000
Due to related party 621,000 399,000
Note payable, related party 8,878,000
Total current liabilities 1,162,000 9,785,000
Deferred tax liability, net 688,000 3,268,000
Total liabilities 1,850,000 13,053,000
Commitments and contingencies (Note 12)
Stockholders’ equity    
Preferred stock, $0.001 par value; 100,000,000 shares authorized, zero shares issued and outstanding (60,496,041 on December 31, 2024); Liquidation value $0.001 per share, zero aggregate. $60,496,041,000 on December 31, 2024). 60,000
Common stock, $0.001 par value; 4,000,000,000 shares authorized, 104,621,231 shares issued and outstanding (11,503,955 on December 31, 2024) 105,000 11,000
Additional paid-in capital 62,011,000 41,857,000
Accumulated deficit (49,507,000) (37,669,000)
Total stockholders’ equity of the Company 12,609,000 4,259,000
Non-controlling interest in subsidiaries 2,946,000 2,978,000
Total stockholders’ equity 15,555,000 7,237,000
Total liabilities and stockholders’ equity $ 17,405,000 $ 20,290,000